Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I interaction study of lascufloxacin (KRP-AM1977X) with theophylline
jRCT2080222510Phase 1Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of lascufloxacin in bacterial disease (2 arms), sponsored by Kyorin Pharmaceutical. Primary endpoints: Pharmacokinetic interaction: Cmax ratio of theophylline with vs without lascufloxacin and Pharmacokinetic interaction: AUC0-10 ratio of theophylline with vs without lascufloxacin. Started May 2014; status: completed.
02
Drugs
lascufloxacin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on jRCT2080222510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222510.